Promon, Sherlita G.
HRN: 28-01-83 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2025
CEFTRIAXONE 1G (VIAL)
10/30/2025
11/05/2025
IV
2g
OD
Pre Op Prophylaxis
Checking Final Appropriateness
10/30/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/30/2025
11/05/2025
IV
500mg
Q8H
Pre Op Prophylaxis
Checking Final Appropriateness